← Current compounder rows

Current NDC auxiliary source row compounder:521

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
71285-0420
Product Ndc
71285-0420
Product Ndc Digits
712850420
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Trophamine 3%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
Proprietary Name Suffix
[empty]
Nonproprietary Name
Trophamine 3%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
Dosage Form Name
SOLUTION
Route Name
INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Central Admixture Pharmacy Services, Inc.
Establishment Name
Central Admixture Pharmacy Services, Inc.
Establishment Fei
[empty]
Substance Name
GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM
Active Ingredients Info
.375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL
History Active Ingredients Raw
GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM
History Active Ingredients Info Raw
.375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL
History Dosage Raw
SOLUTION
Dea Schedule
[empty]
Package Ndc Raw
71285-0420-1
Package Ndc
71285-0420-1
Package Ndc Digits
7128504201
Package Ndc11
71285042001
Package Description
250 mL in 1 BAG (71285-0420-1)
Reporting Period Raw
2025-1
Reporting Period
2025-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:521
Source Row Number
521
Source Row Hash
1e938a934272e6cf679edbf29e0970757e05253618796ae4a80fc31e0de14dd0
Import Run Id
20261015T162751Z
Loaded At
2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "71285-0420",
    "DEASCHEDULE": "",
    "LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
    "SUBSTANCENAME": "GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "71285-0420-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Trophamine 3%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Trophamine 3%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag",
    "PACKAGEDESCRIPTION": "250 mL in 1 BAG (71285-0420-1) ",
    "ACTIVEINGREDIENTSINFO": ".375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:521
Source Row Number
521
Status Scope
package
Lookup Ndc
71285-0420-1
Lookup Ndc Digits
7128504201
Product Ndc
71285-0420
Product Ndc Digits
712850420
Package Ndc
71285-0420-1
Package Ndc Digits
7128504201
Package Ndc11
71285042001
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-1
Reporting Period
2025-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
1e938a934272e6cf679edbf29e0970757e05253618796ae4a80fc31e0de14dd0
Import Run Id
20261015T162751Z
Loaded At
2026-10-15 16:32:20